Concepedia

Publication | Open Access

The <i>BRCA1</i> c. 5096G&gt;A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium

77

Citations

14

References

2017

Year

Abstract

Our results confirm that <i>BRCA1</i>*R1699Q confers an intermediate risk for BC and OC. Breast surveillance for female carriers based on mammogram annually from age 40 is advised. Bilateral salpingo-oophorectomy should be considered based on family history.

References

YearCitations

Page 1